Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 28.87% ...

H.C. Wainwright has recently reiterated Microbot Medical Inc (MBOT) stock to Buy rating, as announced on January 13, 2020, according to Finviz. Earlier, on December 24, 2019, H.C. Wainwright had ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on ATAI Life Sciences (ATAI – Research Report). The associated ...

H.C. Wainwright reiterated its Buy rating and $27.00 price target for CleanSpark Inc. (NASDAQ:CLSK) shares, representing ...

Transcat Inc. (NASDAQ:TRNS), a $923 million market cap company, received a reiterated Buy rating and a $126.00 price target from H.C. Wainwright, despite reporting third-quarter fiscal year 2025 ...

H.C. Wainwright analyst Scott Buck maintained a Buy rating on Transcat (TRNS – Research Report) today and set a price target of $126.00.Invest ...

Equities researchers at HC Wainwright issued their FY2029 EPS estimates for Altimmune in a research note issued on Wednesday, January 22nd. HC Wainwright analyst P. Trucchio forecasts that the company ...

Investment analysts at HC Wainwright issued their FY2024 earnings per share estimates for Genmab A/S in a report issued on ...